DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Loi S, Giobbe-Hurder A, Gombos A. et al.
Abstract GS2-06: Phase Ib/II study evaluating safety and efficacy of pembrolizumab and trastuzumab in patients with trastuzumab-resistant HER2-positive metastatic breast cancer: results from the PANACEA (IBCSG 45-13/BIG 4-13/KEYNOTE-014) study.
Cancer Res 2018;
78: GS2-06-GS02-06
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.